Caribou Biosciences (CRBU) Earnings Date & Reports

Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) genome-editing biopharmaceutical company dedicated to developing transformative therapies for patients with devastating diseases... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

CRBU is expected to report earnings to rise 31.42% to -34 cents per share on August 11

Caribou Biosciences CRBU Stock Earnings Reports

Q2'26

Est.

$-0.34

Q1'26

Beat

by $0.07

Q4'25

Beat

by $0.04

Q3'25

Beat

by $0.05

Q2'25

Beat

by $0.04

The last earnings report on May 07 showed earnings per share of -25 cents, beating the estimate of -33 cents. With 878.18K shares outstanding, the current market capitalization sits at 204.31M.

View a ticker or compare two or three

Compare

CRBU

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

View AI-Driven Trading for CRBU

A.I. Advisor